MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 228 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,575,370 | +1030.2% | 757,537 | +1304.8% | 0.02% | +1400.0% |
| Q2 2023 | $670,288 | -97.3% | 53,925 | -96.9% | 0.00% | -98.1% |
| Q1 2023 | $24,558,675 | -37.4% | 1,752,939 | -36.0% | 0.05% | -40.9% |
| Q4 2022 | $39,219,358 | -26.0% | 2,740,696 | +32.0% | 0.09% | -24.1% |
| Q3 2022 | $53,030,000 | +246.7% | 2,077,036 | +285.8% | 0.12% | +274.2% |
| Q2 2022 | $15,294,000 | -13.5% | 538,356 | +7.4% | 0.03% | -6.1% |
| Q1 2022 | $17,678,000 | +6.9% | 501,212 | +27.0% | 0.03% | +6.5% |
| Q4 2021 | $16,540,000 | -77.4% | 394,808 | -73.5% | 0.03% | -89.8% |
| Q3 2021 | $73,032,000 | +2265.8% | 1,488,016 | +1911.8% | 0.30% | +2064.3% |
| Q2 2021 | $3,087,000 | -63.5% | 73,964 | -68.8% | 0.01% | -64.1% |
| Q1 2021 | $8,453,000 | -17.0% | 237,185 | -34.7% | 0.04% | -29.1% |
| Q4 2020 | $10,181,000 | – | 362,980 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |